nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCC3—Cyclosporine—focal segmental glomerulosclerosis	0.307	0.382	CbGbCtD
Ezetimibe—SLCO1B1—Cyclosporine—focal segmental glomerulosclerosis	0.159	0.197	CbGbCtD
Ezetimibe—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.14	0.173	CbGbCtD
Ezetimibe—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.126	0.157	CbGbCtD
Ezetimibe—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0455	0.0566	CbGbCtD
Ezetimibe—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0273	0.0339	CbGbCtD
Ezetimibe—SOAT1—Statin Pathway—LIPC—focal segmental glomerulosclerosis	0.012	0.103	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of Angiotensinogen to Angiotensins—ACE—focal segmental glomerulosclerosis	0.00775	0.0665	CbGpPWpGaD
Ezetimibe—SOAT1—Statin Pathway—LPL—focal segmental glomerulosclerosis	0.00731	0.0628	CbGpPWpGaD
Ezetimibe—ABCG8—Statin Pathway—LIPC—focal segmental glomerulosclerosis	0.00629	0.054	CbGpPWpGaD
Ezetimibe—ABCG5—Statin Pathway—LIPC—focal segmental glomerulosclerosis	0.00606	0.052	CbGpPWpGaD
Ezetimibe—NPC1L1—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.00537	0.0461	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of Angiotensinogen to Angiotensins—AGT—focal segmental glomerulosclerosis	0.00491	0.0422	CbGpPWpGaD
Ezetimibe—ABCG8—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.00407	0.0349	CbGpPWpGaD
Ezetimibe—ABCG5—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.00392	0.0336	CbGpPWpGaD
Ezetimibe—ABCG8—Statin Pathway—LPL—focal segmental glomerulosclerosis	0.00384	0.033	CbGpPWpGaD
Ezetimibe—NPC1L1—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.0037	0.0317	CbGpPWpGaD
Ezetimibe—ABCG5—Statin Pathway—LPL—focal segmental glomerulosclerosis	0.0037	0.0317	CbGpPWpGaD
Ezetimibe—SOAT1—nephron tubule—focal segmental glomerulosclerosis	0.00357	0.133	CbGeAlD
Ezetimibe—ANPEP—nephron tubule—focal segmental glomerulosclerosis	0.00341	0.128	CbGeAlD
Ezetimibe—NPC1L1—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.00328	0.0281	CbGpPWpGaD
Ezetimibe—ANPEP—kidney—focal segmental glomerulosclerosis	0.003	0.112	CbGeAlD
Ezetimibe—ANPEP—cortex of kidney—focal segmental glomerulosclerosis	0.00292	0.109	CbGeAlD
Ezetimibe—ABCG8—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.0028	0.0241	CbGpPWpGaD
Ezetimibe—ABCG5—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.0027	0.0232	CbGpPWpGaD
Ezetimibe—ABCG8—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.00248	0.0213	CbGpPWpGaD
Ezetimibe—ABCG5—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.00239	0.0205	CbGpPWpGaD
Ezetimibe—UGT2B7—kidney—focal segmental glomerulosclerosis	0.00223	0.0833	CbGeAlD
Ezetimibe—NPC1L1—Lipid and lipoprotein metabolism—ALB—focal segmental glomerulosclerosis	0.00215	0.0185	CbGpPWpGaD
Ezetimibe—ANPEP—Peptide hormone metabolism—ACE—focal segmental glomerulosclerosis	0.00204	0.0175	CbGpPWpGaD
Ezetimibe—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.0395	CcSEcCtD
Ezetimibe—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.0392	CcSEcCtD
Ezetimibe—UGT1A1—kidney—focal segmental glomerulosclerosis	0.00189	0.0708	CbGeAlD
Ezetimibe—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.0325	CcSEcCtD
Ezetimibe—ABCG8—Lipid and lipoprotein metabolism—ALB—focal segmental glomerulosclerosis	0.00163	0.014	CbGpPWpGaD
Ezetimibe—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.0313	CcSEcCtD
Ezetimibe—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.0307	CcSEcCtD
Ezetimibe—SLCO1B1—kidney—focal segmental glomerulosclerosis	0.00158	0.0589	CbGeAlD
Ezetimibe—ABCG5—Lipid and lipoprotein metabolism—ALB—focal segmental glomerulosclerosis	0.00157	0.0135	CbGpPWpGaD
Ezetimibe—ABCC3—kidney—focal segmental glomerulosclerosis	0.0015	0.0559	CbGeAlD
Ezetimibe—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.0277	CcSEcCtD
Ezetimibe—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.00136	0.0508	CbGeAlD
Ezetimibe—ANPEP—Peptide hormone metabolism—AGT—focal segmental glomerulosclerosis	0.00129	0.0111	CbGpPWpGaD
Ezetimibe—ABCC2—kidney—focal segmental glomerulosclerosis	0.00119	0.0447	CbGeAlD
Ezetimibe—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.00116	0.0435	CbGeAlD
Ezetimibe—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0224	CcSEcCtD
Ezetimibe—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0215	CcSEcCtD
Ezetimibe—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.0213	CcSEcCtD
Ezetimibe—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0207	CcSEcCtD
Ezetimibe—SLCO1B1—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.00105	0.00898	CbGpPWpGaD
Ezetimibe—ABCC3—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.00104	0.00893	CbGpPWpGaD
Ezetimibe—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.000992	0.0371	CbGeAlD
Ezetimibe—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000937	0.0182	CcSEcCtD
Ezetimibe—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000934	0.0181	CcSEcCtD
Ezetimibe—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000918	0.0178	CcSEcCtD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—TGFB1—focal segmental glomerulosclerosis	0.000915	0.00786	CbGpPWpGaD
Ezetimibe—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000914	0.0177	CcSEcCtD
Ezetimibe—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000879	0.0171	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000833	0.0162	CcSEcCtD
Ezetimibe—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000799	0.0155	CcSEcCtD
Ezetimibe—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000799	0.0155	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000783	0.0152	CcSEcCtD
Ezetimibe—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000779	0.0151	CcSEcCtD
Ezetimibe—SLCO1B1—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000775	0.00665	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000767	0.00659	CbGpPWpGaD
Ezetimibe—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000756	0.0147	CcSEcCtD
Ezetimibe—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00075	0.0145	CcSEcCtD
Ezetimibe—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000717	0.0139	CcSEcCtD
Ezetimibe—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000712	0.0138	CcSEcCtD
Ezetimibe—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000705	0.0137	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000676	0.0058	CbGpPWpGaD
Ezetimibe—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000666	0.0129	CcSEcCtD
Ezetimibe—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000651	0.0126	CcSEcCtD
Ezetimibe—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000646	0.0125	CcSEcCtD
Ezetimibe—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000634	0.0123	CcSEcCtD
Ezetimibe—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000628	0.0122	CcSEcCtD
Ezetimibe—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000624	0.0121	CcSEcCtD
Ezetimibe—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000615	0.0119	CcSEcCtD
Ezetimibe—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000607	0.0227	CbGeAlD
Ezetimibe—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.0006	0.0117	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000582	0.00499	CbGpPWpGaD
Ezetimibe—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000579	0.0112	CcSEcCtD
Ezetimibe—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000577	0.0112	CcSEcCtD
Ezetimibe—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000571	0.0111	CcSEcCtD
Ezetimibe—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000563	0.0109	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00056	0.00481	CbGpPWpGaD
Ezetimibe—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000545	0.0106	CcSEcCtD
Ezetimibe—ABCC3—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000544	0.00467	CbGpPWpGaD
Ezetimibe—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000539	0.0105	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000537	0.00461	CbGpPWpGaD
Ezetimibe—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000532	0.0103	CcSEcCtD
Ezetimibe—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000532	0.0103	CcSEcCtD
Ezetimibe—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000532	0.0103	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000528	0.0102	CcSEcCtD
Ezetimibe—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000525	0.0102	CcSEcCtD
Ezetimibe—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00052	0.0101	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000517	0.00443	CbGpPWpGaD
Ezetimibe—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000514	0.00997	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000512	0.0044	CbGpPWpGaD
Ezetimibe—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00989	CcSEcCtD
Ezetimibe—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000506	0.00983	CcSEcCtD
Ezetimibe—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0005	0.0097	CcSEcCtD
Ezetimibe—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000499	0.00968	CcSEcCtD
Ezetimibe—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000495	0.00961	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000493	0.00423	CbGpPWpGaD
Ezetimibe—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000489	0.0183	CbGeAlD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000468	0.00402	CbGpPWpGaD
Ezetimibe—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000464	0.00901	CcSEcCtD
Ezetimibe—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000461	0.00894	CcSEcCtD
Ezetimibe—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000458	0.00888	CcSEcCtD
Ezetimibe—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000454	0.00882	CcSEcCtD
Ezetimibe—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000449	0.00871	CcSEcCtD
Ezetimibe—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000443	0.0086	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00044	0.00854	CcSEcCtD
Ezetimibe—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000439	0.00853	CcSEcCtD
Ezetimibe—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000436	0.00846	CcSEcCtD
Ezetimibe—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000436	0.00846	CcSEcCtD
Ezetimibe—ABCB1—kidney—focal segmental glomerulosclerosis	0.00043	0.0161	CbGeAlD
Ezetimibe—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00042	0.00815	CcSEcCtD
Ezetimibe—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000418	0.0156	CbGeAlD
Ezetimibe—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000417	0.00809	CcSEcCtD
Ezetimibe—SLCO1B1—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000405	0.00348	CbGpPWpGaD
Ezetimibe—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000405	0.00786	CcSEcCtD
Ezetimibe—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000403	0.00782	CcSEcCtD
Ezetimibe—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000403	0.00782	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000401	0.00344	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000393	0.00338	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000388	0.00333	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.000385	0.0033	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000375	0.00729	CcSEcCtD
Ezetimibe—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000366	0.0071	CcSEcCtD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000363	0.00311	CbGpPWpGaD
Ezetimibe—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000361	0.007	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000355	0.00305	CbGpPWpGaD
Ezetimibe—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000349	0.00677	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000342	0.00293	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000342	0.00293	CbGpPWpGaD
Ezetimibe—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000337	0.00654	CcSEcCtD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000333	0.00286	CbGpPWpGaD
Ezetimibe—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000324	0.00629	CcSEcCtD
Ezetimibe—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000321	0.00624	CcSEcCtD
Ezetimibe—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000321	0.00623	CcSEcCtD
Ezetimibe—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000319	0.0062	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000307	0.00264	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000304	0.00261	CbGpPWpGaD
Ezetimibe—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000303	0.00587	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000301	0.00258	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000292	0.00251	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000277	0.00238	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000275	0.00236	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000259	0.00222	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000249	0.00214	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	0.000244	0.00209	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000233	0.002	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000231	0.00199	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.00023	0.00197	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000228	0.00196	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000226	0.00194	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000224	0.00193	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000222	0.0019	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000219	0.00188	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000213	0.00183	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00021	0.0018	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—LPL—focal segmental glomerulosclerosis	0.000209	0.00179	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000202	0.00174	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	0.0002	0.00172	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000196	0.00168	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	0.000191	0.00164	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—AGT—focal segmental glomerulosclerosis	0.000178	0.00153	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.000168	0.00144	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—LPL—focal segmental glomerulosclerosis	0.000158	0.00136	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—LPL—focal segmental glomerulosclerosis	0.000152	0.00131	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000149	0.00128	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000149	0.00128	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000149	0.00128	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000146	0.00125	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000138	0.00118	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ALB—focal segmental glomerulosclerosis	0.000137	0.00118	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—AGT—focal segmental glomerulosclerosis	0.000135	0.00116	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.000132	0.00113	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000131	0.00113	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AGT—focal segmental glomerulosclerosis	0.00013	0.00112	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000128	0.0011	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000125	0.00107	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000118	0.00102	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.000112	0.000964	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.000112	0.000964	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000111	0.000954	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000109	0.000937	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—ALB—focal segmental glomerulosclerosis	0.000104	0.000891	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000103	0.00088	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ALB—focal segmental glomerulosclerosis	9.99e-05	0.000858	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	9.78e-05	0.00084	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	9.49e-05	0.000815	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	9.12e-05	0.000783	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	9.1e-05	0.000782	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—LPL—focal segmental glomerulosclerosis	8.9e-05	0.000764	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	8.9e-05	0.000764	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	8.33e-05	0.000715	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—LIPC—focal segmental glomerulosclerosis	7.81e-05	0.000671	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	7.79e-05	0.000669	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AGT—focal segmental glomerulosclerosis	7.62e-05	0.000654	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	7.56e-05	0.000649	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CTGF—focal segmental glomerulosclerosis	6.88e-05	0.000591	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	6.84e-05	0.000587	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.78e-05	0.000582	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—LIPC—focal segmental glomerulosclerosis	6.64e-05	0.00057	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—LIPC—focal segmental glomerulosclerosis	6.64e-05	0.00057	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.34e-05	0.000544	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	5.98e-05	0.000513	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CTGF—focal segmental glomerulosclerosis	5.85e-05	0.000502	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CTGF—focal segmental glomerulosclerosis	5.85e-05	0.000502	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ALB—focal segmental glomerulosclerosis	5.84e-05	0.000502	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.8e-05	0.000498	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	5.68e-05	0.000488	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	5.4e-05	0.000464	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.39e-05	0.000463	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.39e-05	0.000463	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	5.13e-05	0.000441	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—LIPC—focal segmental glomerulosclerosis	4.95e-05	0.000425	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—LPL—focal segmental glomerulosclerosis	4.77e-05	0.000409	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.75e-05	0.000408	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—LIPC—focal segmental glomerulosclerosis	4.58e-05	0.000393	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.51e-05	0.000387	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.45e-05	0.000382	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.38e-05	0.000376	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.36e-05	0.000374	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.23e-05	0.000363	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AGT—focal segmental glomerulosclerosis	4.08e-05	0.00035	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—LPL—focal segmental glomerulosclerosis	4.05e-05	0.000348	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—LPL—focal segmental glomerulosclerosis	4.05e-05	0.000348	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CTGF—focal segmental glomerulosclerosis	4.03e-05	0.000346	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.01e-05	0.000345	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.92e-05	0.000336	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.72e-05	0.000319	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AGT—focal segmental glomerulosclerosis	3.47e-05	0.000298	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AGT—focal segmental glomerulosclerosis	3.47e-05	0.000298	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	3.37e-05	0.00029	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—LPL—focal segmental glomerulosclerosis	3.29e-05	0.000283	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALB—focal segmental glomerulosclerosis	3.13e-05	0.000269	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—LPL—focal segmental glomerulosclerosis	3.02e-05	0.000259	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AGT—focal segmental glomerulosclerosis	2.82e-05	0.000242	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—LPL—focal segmental glomerulosclerosis	2.8e-05	0.00024	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALB—focal segmental glomerulosclerosis	2.66e-05	0.000229	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALB—focal segmental glomerulosclerosis	2.66e-05	0.000229	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AGT—focal segmental glomerulosclerosis	2.58e-05	0.000222	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.48e-05	0.000213	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AGT—focal segmental glomerulosclerosis	2.39e-05	0.000205	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.18e-05	0.000187	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALB—focal segmental glomerulosclerosis	2.16e-05	0.000186	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.12e-05	0.000182	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.01e-05	0.000172	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALB—focal segmental glomerulosclerosis	1.98e-05	0.00017	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALB—focal segmental glomerulosclerosis	1.84e-05	0.000158	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.53e-05	0.000131	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	1.51e-05	0.00013	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.34e-05	0.000115	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	1.29e-05	0.000111	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.24e-05	0.000106	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	9.92e-06	8.52e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	9.31e-06	7.99e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	7.97e-06	6.84e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	6.11e-06	5.25e-05	CbGpPWpGaD
